ARCHIVES

Trial Data: No Benefit In Adding Perifosine to Capecitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001

Magnuson In Line For Appropriations Chairmanship

December 2, 1977

New Saccharin Studies Convince FDA It A Carcinogen

July 15, 1977

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

May 29, 2009

NCI By Pass Budget For FY 1987 Is $1.57 Bil.

October 18, 1985

Duke Comprehensive Cancer Center Wins Core Grant Renewal

September 17, 2010